| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 48.215 | 77.732 | 76.042 | 85.786 |
| Total Income - EUR | - | - | - | - | - | - | 48.215 | 77.760 | 76.045 | 85.786 |
| Total Expenses - EUR | - | - | - | - | - | - | 37.654 | 64.070 | 131.636 | 104.201 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 10.561 | 13.690 | -55.591 | -18.416 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 10.391 | 12.305 | -56.352 | -20.975 |
| Employees | - | - | - | - | - | - | 1 | 1 | 1 | 2 |
Check the financial reports for the company - Keolamed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 49.696 | 138.413 | 163.057 | 156.880 |
| Current Assets | - | - | - | - | - | - | 18.535 | 45.237 | 12.076 | 1.849 |
| Inventories | - | - | - | - | - | - | 6.540 | 26.313 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 308 | 17.963 | 5.043 | 763 |
| Cash | - | - | - | - | - | - | 11.686 | 961 | 7.032 | 1.086 |
| Shareholders Funds | - | - | - | - | - | - | 10.431 | 22.715 | -33.706 | -54.622 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 57.800 | 160.936 | 208.838 | 213.351 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Keolamed S.r.l.